Salim Bushra, Rashid Saima, Ali M Asghar, Raza Amir, Khan Fauzia A
Anaesthesiology, Aga Khan University, Karachi, PAK.
Cureus. 2019 Dec 20;11(12):e6427. doi: 10.7759/cureus.6427.
Background Several drugs have been tried to obtund the hemodynamic extubation response but all have variable side effects that may affect the quality of short-term recovery. Objective Our primary objective was to evaluate the effect of pharmacological agents, such as dexmedetomidine, local anesthetics, and so on, administered for attenuating the extubation response on the quality of extubation, as judged by the presence or absence of cough, sedation, and laryngospasm/bronchospasm in adult patients who had undergone general anesthesia. A secondary objective was to evaluate the effect of these drugs on other immediate post-extubation complications such as respiratory depression, desaturation, bradycardia, hypotension, and nausea and vomiting (PONV). Methods This is a systematic review of (randomized controlled trials)RCTs with meta-analysis. The Medical Literature Analysis and Retrieval System Online (MEDLINE), Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched for RCTs on the effect of pharmacological agents on both the hemodynamic extubation response as well as the quality of extubation. Results Fourteen out of 24 included studies were subjected to a meta-analysis. The risk of cough was less likely in the intervention group as compared to control groups (OR 0.26, 95% CI 0.15 to 0.46, p<0.00001, I=35%). Sedation, hypotension (OR= 10.47; 95% CI: 1.86, 58.80, p=0.008, I=0%), and bradycardia (OR= 6.57; 95% CI: 2.09, 20.64, p=0.001, I=0%) were reported with dexmedetomidine. Only one study reported laryngospasm with dexmedetomidine and two studies with opioids. Conclusion Dexmedetomidine 0.4 to 0.5 ug/kg was associated with smooth extubation, minimal coughing, no laryngospasm/ bronchospasm, and with stable hemodynamics, without causing respiratory depression, PONV, and desaturation. However, in higher doses (more than 0.5 ug/kg), it caused bradycardia, hypotension, and sedation. Other pharmacological agents, such as local anesthetics, calcium channel blockers, and opioids, did not attenuate cough associated with extubation.
已尝试多种药物来减轻拔管时的血流动力学反应,但所有药物都有不同的副作用,可能会影响短期恢复质量。目的:我们的主要目的是评估药物(如右美托咪定、局部麻醉药等)用于减轻拔管反应对拔管质量的影响,通过判断接受全身麻醉的成年患者拔管时是否存在咳嗽、镇静以及喉痉挛/支气管痉挛来评估。次要目的是评估这些药物对其他拔管后即刻并发症的影响,如呼吸抑制、血氧饱和度下降、心动过缓、低血压以及恶心和呕吐(术后恶心呕吐)。方法:这是一项对随机对照试验(RCT)进行的系统评价并荟萃分析。检索了医学文献分析与联机检索系统(MEDLINE)、护理及相关健康文献累积索引(CINAHL)以及Cochrane对照试验中央注册库(CENTRAL)数据库,以查找关于药物对血流动力学拔管反应以及拔管质量影响的RCT。结果:纳入的24项研究中有14项进行了荟萃分析。与对照组相比,干预组咳嗽风险较低(比值比0.26,95%置信区间0.15至0.46,p<0.00001,I²=35%)。右美托咪定导致镇静、低血压(比值比=10.47;95%置信区间:1.86,58.80,p=0.008,I²=0%)和心动过缓(比值比=6.57;95%置信区间:2.09,20.64,p=0.001,I²=0%)。仅有一项研究报道右美托咪定引起喉痉挛,两项研究报道阿片类药物引起喉痉挛。结论:0.4至0.5μg/kg的右美托咪定与平稳拔管、轻微咳嗽、无喉痉挛/支气管痉挛以及血流动力学稳定相关,且不会引起呼吸抑制、术后恶心呕吐和血氧饱和度下降。然而,高剂量(超过0.5μg/kg)时会导致心动过缓、低血压和镇静。其他药物,如局部麻醉药、钙通道阻滞剂和阿片类药物,并未减轻与拔管相关的咳嗽。